Timber Pharmaceuticals Inc. (TMBR) Fundamentals

Timber Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. It is initially focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis, facial angiofibromas in tuberous sclerosis complex, and scleroderma. The company's development pipeline includes TMB-001 (Topical Isotretinoin), TMB-002 (Topical Rapamycin), and TMB-003 (Topical / Subcutaneous ET-A Receptor Antagonist).
SHARE INFORMATION
Market Cap$ 20,026,994
Shares Outstanding63,678,836
Float63,487,790
Percent Float99.7%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 295,738
Latest Fiscal EPS$ -0.26
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions42
Institutional Holdings Date2022-05-31
Institutional Bought Previous 3 Months246,747
Institutional Holdings Percent8.8%
Institutional Sold Previous 3 Months312,848
Insider Holdings Date2022-05-31
Insider Bought Previous 3 Months-
Insider Holdings Percent0.9
Insider Sold Previous 3 Months-
Insider Shares Owned554,696
TRADING INFO
52 Week High$ 1.23
52 Week Low$ 0.23
52 Week High Change$ -74.22
21 Day Moving Average$ 0.298
21 Day Extended Moving Average$ 0.294954
50 Day Moving Average$ 0.2812
50 Day Extended Moving Average$ 0.294971
200 Day Moving Average$ 0.429477
200 Day Extended Moving Average$ 0.505474
10 Day Average Volume728,719
20 Day Average Volume1,158,564
30 Day Average Volume2,415,992
50 Day Average Volume2,269,533
Alpha-0.076710
Beta0.4071
Standard Deviation0.258408
R20.005565
7 Day Price Change$ 0.0207
7 Day Percent Change7.05%
21 Day Price Change$ -0.0019
21 Day Percent Change-0.6%
30 Day Price Change$ 0.0195
30 Day Percent Change6.61%
Month to Date Price Change$ 0.0195
Month to Date Percent Change6.61%
Quarter to Date Price Change$ -0.0705
Quarter to Date Percent Change-18.31%
180 Day Price Change$ -0.0655
180 Day Percent Change-17.24%
200 Day Price Change$ -0.1005
200 Day Percent Change-24.22%
Year to Date Price Change$ -0.0655
Year to Date Percent Change-17.24%

Timber Pharmaceuticals Inc. (TMBR) Key Ratios

PROFITABILITY
EBIT Margin-3,989.6%
EBITDA Margin-3,890.1%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 41,846
Revenue Per Share$ 0.0007
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.90
Total Debt To Equity0.10
Int Coverage-169.00
Current Ratio3.60
Leverage Ratio1.40
Quick Ratio3.50
Long Term Debt To Capital0.02
VALUATION MEASURES
PE Ratio-1.20
Enterprise Value$ 6,296,320
Price to Sales478.588
Price to Free Cash-2.40
PE High Last 5 Years0.00
Price To Book1.90
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book1.90
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.30
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-97.19
Return on Equity-146.29
Return on Capital-133.25

Timber Pharmaceuticals Inc. (TMBR) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKPMG LLP
CEOJohn Koconis
Emplyoees5
Last AuditUE
CIK0001504167
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address110 Allen Road
Suite 401
Basking Ridge, NJ 7920
Websitehttps://www.timberpharma.com
Facsimile-
Telephone+1 973 314-9577
Emailinfo@timberpharma.com


Your Recent History
AMEX
TMBR
Timber Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.